Ensysce Biosciences, Inc. (ENSC)
$0.39-$0.01 (-1.54%) Today
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 2 | 908,614 | $444K |
| Other acquisition / disposition | 1 | 254,307 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
1 Form 4 filing on record, the earliest from Aug 18, 2026, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Bob G. Gower - Director | Open-market purchase | Common Stock | 508,614 | $0.48 | $246K | |
| Bob G. Gower - Director | Open-market purchase | Common Stock | 400,000 | $0.50 | $198K | |
| Bob G. Gower - Director | Other | Warrant | 254,307 | - | - |
Ensysce Biosciences, Inc. (ENSC) had 1 insider filing in the last 90 days, with the most recent on 2026-08-18. The full record for ENSC runs to 1 Form 4 filing, the earliest from 2026-08-18. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
2 insider purchases of ENSC were filed in the last 90 days, totaling $444K.
No insider sales of ENSC were filed in the last 90 days.
This page tracks ENSC Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add ENSC to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
$ENTENTRATA, INC.
$ENVENVESTNET, INC.
$ENVBEnveric Biosciences, Inc.
$ENXEaton Vance New York Municipal Bond Fund
$ENZNDViskase Holdings, Inc.
$EODALLSPRING GLOBAL DIVIDEND OPPORTUNITY FUND
$EOHCEdison Oncology Holding Corp
$EOIEaton Vance Enhanced Equity Income Fund
$EOSEaton Vance Enhanced Equity Income Fund II
$EPWKFEPWK Holdings Ltd.Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.